Headline News about In8Bio Inc
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022
November 11, 2022
Via Benzinga
Via Benzinga
IN8bio's Leukemia Cell Therapy Shows Durable Response
July 27, 2022
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|